BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35597513)

  • 1. Artificial intelligence in virtual screening: Models versus experiments.
    Arul Murugan N; Ruba Priya G; Narahari Sastry G; Markidis S
    Drug Discov Today; 2022 Jul; 27(7):1913-1923. PubMed ID: 35597513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
    Zhang L; Tan J; Han D; Zhu H
    Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
    Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
    Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranking chemical structures for drug discovery: a new machine learning approach.
    Agarwal S; Dugar D; Sengupta S
    J Chem Inf Model; 2010 May; 50(5):716-31. PubMed ID: 20387860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing the integration of virtual and experimental screening in hit discovery.
    Bajusz D; Keserű GM
    Expert Opin Drug Discov; 2022 Jun; 17(6):629-640. PubMed ID: 35671403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning in image-based phenotypic drug discovery.
    Krentzel D; Shorte SL; Zimmer C
    Trends Cell Biol; 2023 Jul; 33(7):538-554. PubMed ID: 36623998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence: Machine learning approach for screening large database and drug discovery.
    Parvatikar PP; Patil S; Khaparkhuntikar K; Patil S; Singh PK; Sahana R; Kulkarni RV; Raghu AV
    Antiviral Res; 2023 Dec; 220():105740. PubMed ID: 37935248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning classification can reduce false positives in structure-based virtual screening.
    Adeshina YO; Deeds EJ; Karanicolas J
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18477-18488. PubMed ID: 32669436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between machine learning and natural products cheminformatics: Application to the lead discovery of anthraquinone derivatives.
    Moshawih S; Goh HP; Kifli N; Idris AC; Yassin H; Kotra V; Goh KW; Liew KB; Ming LC
    Chem Biol Drug Des; 2022 Aug; 100(2):185-217. PubMed ID: 35490393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review on Parallel Virtual Screening Softwares for High-Performance Computers.
    Murugan NA; Podobas A; Gadioli D; Vitali E; Palermo G; Markidis S
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries.
    Sivula T; Yetukuri L; Kalliokoski T; Käsnänen H; Poso A; Pöhner I
    J Chem Inf Model; 2023 Sep; 63(18):5773-5783. PubMed ID: 37655823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent applications of artificial intelligence in RNA-targeted small molecule drug discovery.
    Morishita EC; Nakamura S
    Expert Opin Drug Discov; 2024 Apr; 19(4):415-431. PubMed ID: 38321848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence in Drug Safety and Metabolism.
    Smith GF
    Methods Mol Biol; 2022; 2390():483-501. PubMed ID: 34731484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
    Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
    Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streamlining Large Chemical Library Docking with Artificial Intelligence: the PyRMD2Dock Approach.
    Roggia M; Natale B; Amendola G; Di Maro S; Cosconati S
    J Chem Inf Model; 2024 Apr; 64(7):2143-2149. PubMed ID: 37552222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CADD, AI and ML in drug discovery: A comprehensive review.
    Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
    Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in machine intelligence-driven virtual screening approaches for big-data.
    Kumar N; Acharya V
    Med Res Rev; 2024 May; 44(3):939-974. PubMed ID: 38129992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.